dalteparin has been researched along with 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bosshart, H; Heinzelmann, M | 1 |
1 other study(ies) available for dalteparin and 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
Article | Year |
---|---|
Heparin binds to lipopolysaccharide (LPS)-binding protein, facilitates the transfer of LPS to CD14, and enhances LPS-induced activation of peripheral blood monocytes.
Topics: Acute-Phase Proteins; Adjuvants, Immunologic; Antithrombin III; Biological Transport; Boron Compounds; Carrier Proteins; Enoxaparin; Fluorescent Dyes; Heparin; Humans; Interleukin-8; Lipopolysaccharide Receptors; Lipopolysaccharides; Membrane Glycoproteins; Monocytes; Signal Transduction; Solubility; Sulfates; Teichoic Acids; Thrombin | 2005 |